LMAT

LEMAITRE VASCULAR INC

LMAT·525558201·US·Common Stock·Healthcare - Medical Instruments & Supplies-13D/G

LMAT (LEMAITRE VASCULAR INC) is held by 145 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($314.1M), FIRST TRUST ADVISORS LP ($104.9M), CONGRESS ASSET MANAGEMENT CO ($92.5M). Net institutional sentiment: Mixed.

145
Holders
(13 Elite)
$1.6B
Total Value
57% (152)
Consensus
87 buying - 65 selling
13F: Insider & Congress: Updated regularly
LMAT

Smart Money Verdict

View all
Loading verdict
Held by 145 funds
13 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders May 11, 2026 · Activists Jul 27, 2026 · Congress none

ActivistFTFirst Trust Portfolios L.P.5.2%Jul 27, 2026
ActivistGWGeorge W. LeMaitre6.4%May 14, 2026
InsiderKGKamke Trent GSell $313KMay 8, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.3M(+4.1%)$314.1M0.0%-12.32%
32
Increased
1.1M(+9.6%)$104.9M0.1%-6.33%
33
Increased
963,706(+15.5%)$92.5M0.6%+7.79%
48
Increased
953,437(+4.5%)$91.5M0.0%-26.30%
31
Increased
901,416(+5.3%)$86.5M0.0%+27.69%
31
Increased
788,835(+19.8%)$75.7M0.0%+29.26%
35
Increased
604,833(+7.5%)$58M0.0%-26.07%
32
Increased
493,889(+3.7%)$47.4M0.0%+51.41%
30
Increased
473,194(+9.4%)$45.4M0.0%-8.58%
32
Increased
448,389(+34.3%)$43M0.0%-17.32%
38
Decreased
351,083(-13.9%)$33.7M0.0%-3.73%
0
Increased
333,325(+6.7%)$32M0.0%+86.33%
31
Increased
316,528(+12.3%)$30.4M0.0%-15.79%
32
Increased
308,765(+13.2%)$29.6M0.0%-6.20%
33
Increased
247,804(+498.3%)$23.8M0.0%-14.88%
46
Decreased
244,729(-10.8%)$23.5M0.0%+38.93%
0
Decreased
220,497(-4.4%)$21.2M0.1%-10.68%
0
Increased
206,764(+51.3%)$19.8M0.0%-4.29%
39
Increased
206,279(+4.2%)$19.8M0.0%+63.28%
30
Increased
181,015(+80.2%)$17.4M0.1%-22.58%
43

Showing 1-20 of 162

1 / 9
LMATLMATLEMAITRE VASCULAR INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used